Unknown

Dataset Information

Targeting cellular cathepsins inhibits hepatitis E virus entry.


ABSTRACT:

Background and aims

HEV is estimated to be responsible for 70,000 deaths annually, yet therapy options remain limited. In the pursuit of effective antiviral therapies, targeting viral entry holds promise and has proven effective for other viruses. However, the precise mechanisms and host factors required during HEV entry remain unclear. Cellular proteases have emerged as host factors required for viral surface protein activation and productive cell entry by many viruses. Hence, we investigated the functional requirement and therapeutic potential of cellular protease during HEV infection.

Approach and results

Using our established HEV cell culture model and subgenomic HEV replicons, we found that blocking lysosomal cathepsins (CTS) with small molecule inhibitors impedes HEV i

SUBMITTER: Klohn M 

PROVIDER: S-EPMC11486972 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature